Latest developments in cystic fibrosis

Poster Discussion
Chairs: M. Stahl (Heidelberg, Germany), J. Davies (London, United Kingdom)
Synergistic activity of colistin in combination with N-acetylcysteine against colistin-resistant Acinetobacter Baumannii grown in biofilms
F. Sergio (Bresso, Italy), S. Pollini (Firenze, Italy), S. Boncompagni (Siena, Italy), T. Di Maggio (Siena, Italy), S. Aliberti (Milano, Italy), F. Blasi (Milano, Italy), L. Pallecchi (Firenze, Italy), G. Rossolini1 (Firenze, Italy)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Safety and efficacy of intravenous (IV) Fosfomycin in adult cystic fibrosis patients
C. Biglia (Orbassano (TO), Italy), C. Bena (Orbassano (TO), Italy), G. Bonizzoni (Orbassano (TO), Italy), M. Bellocchia (Orbassano (TO), Italy), A. Grande (Orbassano (TO), Italy), F. Traversa (Orbassano (TO), Italy), E. Clivati (Orbassano (TO), Italy), G. Bandelli (Orbassano (TO), Italy), S. Demichelis (Orbassano (TO), Italy), C. Albera (Orbassano (TO), Italy), B. Messore (Orbassano (TO), Italy)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Azoles therapeutic drug monitoring and fungal antimicrobial resistance in adults with Cystic Fibrosis
M. Di Paolo (London, United Kingdom), K. Dave (London, United Kingdom), A. Vijayasingam (London, United Kingdom), R. Sheth (London, United Kingdom), E. Luke (London, United Kingdom), A. Scourfield (London, United Kingdom), L. Nwankwo (London, United Kingdom), S. Schelenz (London, United Kingdom), J. Elborn (London, United Kingdom), D. Armstrong-James (London, United Kingdom), A. Shah (London, United Kingdom)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
The prevalence and diversity of fungi in respiratory samples of cystic fibrosis patients – a Dutch, nationwide, prospective, multicentre study
T. Engel (Nijmegen, Netherlands), L. Slabbers (Nijmegen, Netherlands), C. De Jong (Nijmegen, Netherlands), W. Melchers (Nijmegen, Netherlands), F. Hagen (Nijmegen, Netherlands), P. Verweij (Nijmegen, Netherlands), P. Merkus (Nijmegen, Netherlands), J. Meis (Nijmegen, Netherlands)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Identification of disease specific biomarkers by exhalomics using Secondary Electrospray Ionisation High-resolution Mass Spectrometry (SESI-HRMS) in children with cystic fibrosis
K. Heschl (ZH, Switzerland), N. Haas-Baumann (ZH, Switzerland), R. Weber (ZH, Switzerland), A. Baghdasaryan (ZH, Switzerland), S. Micic (ZH, Switzerland), F. Singer (ZH, Switzerland), R. Zenobi (ZH, Switzerland), T. Bruderer (ZH, Switzerland), A. Möller (ZH, Switzerland)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Detection of Pseudomonas aeruginosa infection in cystic fibrosis patients by eNose technology
M. Lammers (Amsterdam, Netherlands), R. Kos (Amsterdam, Netherlands), R. De Vries (Amsterdam, Netherlands), P. Brinkman (Amsterdam, Netherlands), J. Dagelet (Amsterdam, Netherlands), N. Rutjes (Amsterdam, Netherlands), C. Majoor (Amsterdam, Netherlands), S. Terheggen-Lagro (Amsterdam, Netherlands), E. Weersink (Amsterdam, Netherlands), L. Bos (Amsterdam, Netherlands), P. Sterk (Amsterdam, Netherlands), A. Maitland-Van Der Zee (Amsterdam, Netherlands), A. Neerincx & The Amsterdam Cf Research Group (Amsterdam, Netherlands)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Reduced uptake of inhaled carbon in airway macrophages from children with cystic fibrosis
N. Liu (London, United Kingdom), L. Miyashita (London, United Kingdom), J. Grigg (London, United Kingdom)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Retrospective analysis of treatment with Ivacaftor/Lumacaftor in patients with cystic fibrosis at the Munich Cystic Fibrosis Centers
S. Naehrig (Munich, Germany), P. Mertsch (Munich, Germany), M. Griese (Munich, Germany), M. Kappler (Munich, Germany), R. Huber (Munich, Germany)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Effects of Lumacaftor-Ivacaftor Therapy on CFTR Function in Phe508del Homozygous Patients with Cystic Fibrosis
S. Gräber (Heidelberg, Germany), C. Dopfer (Hannover, Germany), L. Naehrlich (Giessen, Germany), L. Gyulumyan (Hannover, Germany), H. Scheuermann (Heidelberg, Germany), S. Hirtz (Heidelberg, Germany), S. Wege (Heidelberg, Germany), H. Mairbaeurl (Heidelberg, Germany), M. Dorda (Hannover, Germany), R. Hyde (Hannover, Germany), A. Bagheri-Hanson (Giessen, Germany), C. Rueckes-Nilges (Giessen, Germany), S. Fischer (Hannover, Germany), M. Mall (Heidelberg, Germany), B. Tuemmler (Hannover, Germany)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Noninvasive ventilation (NPPV) affects Pulmonary Exacerbation (PE) rate in Cystic Fibrosis children (CFc).
L. Appendini (Saluzzo (CN), Italy), L. Ronco (Torino, Italy), G. Ferreyra (Torino, Italy), I. Esposito (Torino, Italy), E. Bignamini (Torino, Italy)
Congress or journal article abstractWebcastSlide presentationE-poster
Congress or journal article abstractWebcastSlide presentationE-poster
Exercise capacity in patients with cystic fibrosis at 6 and 12 months after lung transplantation
M. Damin (Padova, Italy), M. De Toni (Padova, Italy), M. Marchi (Padova, Italy), G. Foltran (Padova, Italy), E. Bazzan (Padova, Italy), G. Turato (Padova, Italy), M. Saetta (Padova, Italy), M. Cosio (Montreal , Canada)
Congress or journal article abstract
Congress or journal article abstract
Acute effects of combined exercise and oscillatory positive expiratory pressure therapy on sputum properties and lung diffusing capacity in cystic fibrosis: a randomized, controlled, crossover trial
T. Radtke (Zurich, Switzerland), L. Boeni (Zurich, Switzerland), P. Bohnacker (Zurich, Switzerland), M. Maggi-Bebba (Zurich, Switzerland), P. Fischer (Zurich, Switzerland), S. Kriemler (Zurich, Switzerland), C. Benden (Zurich, Switzerland), H. Dressel (Zurich, Switzerland)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Risk factors for early lung function decline in young children with Cystic Fibrosis
J. Balinotti (Buenos Aires , Argentina), D. Chang (Buenos Aires , Argentina), V. Rodriguez (Buenos Aires , Argentina), S. Lubovich (Buenos Aires , Argentina), S. Zaragoza (Buenos Aires , Argentina), N. Escobar (Buenos Aires , Argentina), C. Kofman (Buenos Aires , Argentina), L. Perez (Buenos Aires , Argentina), V. Ardiles (Buenos Aires , Argentina), A. Teper (Buenos Aires , Argentina)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
The TLR4 regulator miR-21 is downregulated in the paediatric cystic fibrosis airway
A. Glasgow (Dublin, Ireland), S. Vencken (Dublin, Ireland), C. De Santi (Dublin, Ireland), R. Raoof (Dublin, Ireland), D. Henshall (Dublin, Ireland), B. Linnane (Limerick, Ireland), P. Mcnally (Dublin, Ireland), C. Greene (Dublin, Ireland)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
HspB5 in Cystic Fibrosis
F. Degrugillier (Créteil, France), X. Decrouy (Créteil, France), V. Prulière-Escabasse (Créteil, France), C. Jiang (Toronto, Canada), D. Rotin (Toronto, Canada), P. Fanen (Créteil, France), S. Simon (Créteil, France)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Large phenotypic spectrum associated with two new deep intronic variants on the CFTR gene
A. BERGOUGNOUX (Montpellier, France), K. Deletang (Montpellier, France), J. Varilh (Montpellier, France), F. Houriez (Paris, France), J. Altieri (Montpellier, France), M. Koenig (Montpellier, France), C. Férec (Brest, France), C. Mireille (Montpellier, France), T. Bienvenu (Paris, France), M. Audrezet (Brest, France), A. Pagin (Lille, France), E. Girodon (Paris, France), C. Raynal (Montpellier, France), M. Taulan-Cadars (Montpellier, France)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
PRO-INFLAMMATORY ACTIVITY AND OXIDATIVE STRESS ON A LINE OF CYSTIC FIBROSIS (CF) HUMAN RESPIRATORY EPITHELIUM
J. Figueroa (Buenos Aires, Argentina), M. Clauzure (Buenos Ai, Argentina), Á. Valdivieso (Buenos Ai, Argentina), M. Massip-Copiz (Buenos Ai, Argentina), C. Mori (Buenos Ai, Argentina), A. Dugour (Buenos Aires, Argentina), D. Primrose (Buenos Aires, Argentina), T. Santa Coloma (Buenos Aires, Argentina)
Congress or journal article abstractWebcastSlide presentation
Congress or journal article abstractWebcastSlide presentation
Plasma ceramides and sphingomyelins increase in primary ciliary dyskinesia but decrease in cystic fibrosis
D. Bal Topcu (Ankara, Turkey), G. Tugcu (Ankara, Turkey), F. Ozcan (Antalya, Turkey), M. Aslan (Antalya, Turkey), S. Esref (Ankara, Turkey), M. Gharibzadeh Hizal (Ankara, Turkey), E. Elmas Yalcin (Ankara, Turkey), D. Dogru Ersoz (Ankara, Turkey), U. Ozcelik (Ankara, Turkey), N. Kiper (Ankara, Turkey), I. Lay (Ankara, Turkey), Y. Oztas (Ankara, Turkey)
Congress or journal article abstractE-poster
Congress or journal article abstractE-poster